TPMT GENOTYPE BY RT-PCR
MRP - ₹ 7,110
What is a TPMT GENOTYPE BY RT-PCR?
The TPMT Genotype by RT-PCR test is a genetic analysis that identifies variations in the Thiopurine Methyltransferase (TPMT) gene using Real-Time Polymerase Chain Reaction (RT-PCR). TPMT is an enzyme responsible for metabolizing thiopurine drugs, which are commonly prescribed for leukemia, autoimmune disorders, and organ transplant patients. The purpose of this test is to determine whether a patient has normal, reduced, or absent TPMT activity, helping clinicians adjust drug dosages to prevent severe toxicity and ensure safe, effective treatment.
Additional Information
| Also known as/ Other names: | Thiopurine Methyltransferase Genotyping, TPMT Mutation Analysis, TPMT Pharmacogenetic Test, TPMT Gene Polymorphism Test |
| Parameters: | 1 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood |
| Patient Preparation: | No prior preparation is needed |
| Reports: | 3 days |
FAQs
It helps determine safe thiopurine drug dosages, preventing severe toxicity in patients with reduced or absent TPMT enzyme activity.
Patients prescribed thiopurine drugs for leukemia, autoimmune disorders, or organ transplants are recommended for TPMT testing.
Positive results indicate reduced TPMT activity, requiring lower thiopurine doses to avoid toxicity.
A negative result suggests normal TPMT activity, allowing standard thiopurine dosing.
Without testing, patients may receive unsafe thiopurine doses, leading to severe side effects or bone marrow suppression.
Yes, it is safe and often performed in pediatric patients requiring thiopurine therapy.
No, medications do not interfere with genetic sequencing results.
Genotyping detects genetic variants, while enzyme activity testing measures functional TPMT levels directly.
Mutations are linked to thiopurine drug intolerance, bone marrow suppression, and severe side effects.